Natera NTRA
Natera is a genetic diagnostics company offering non-invasive prenatal tests and minimal residual disease (MRD) detection through its Signatera platform, selling its tests to hospitals, clinics, and patients. Natera is growing strongly (revenue +37.7%) and its Signatera platform is gaining international traction with the Japan approval, but profitability is negative (operating margin -10.29%, ROE -12.54%) and valuation is very demanding (FCF yield 0.17%), making it vulnerable to a high-rate environment.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Natera is a genetic diagnostics company offering non-invasive prenatal tests and minimal residual disease (MRD) detection through its Signatera platform, selling its tests to hospitals, clinics, and patients. Natera is growing strongly (revenue +37.7%) and its Signatera platform is gaining international traction with the Japan approval, but profitability is negative (operating margin -10.29%, ROE -12.54%) and valuation is very demanding (FCF yield 0.17%), making it vulnerable to a high-rate environment.
Score by category
| Category | Score |
|---|---|
| Financial health | 3.8 |
| Quality / Moat | 3.0 |
| Valuation | 0.6 |
| Growth | 9.4 |
| Dividend | 1.5 |
| Momentum | 9.8 |
| Risk & Context | 3.3 |
OVERALL SCORE: 3.9/10
Context and risks
The rise in 10-year yields (5.17%) penalizes high-growth companies with demanding valuations like Natera (PER not available, but FCF yield 0.17% and growth of 37.7% indicate long duration). However, the effect is moderate because the company is not highly leveraged (DN/EBITDA 3.8, albeit with negative EBITDA).
News considered in the analysis
- Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx — Aprobación regulatoria en Japón para un nuevo uso de Signatera; amplía el mercado direccionable y refuerza la posición competitiva.
- NTRA Stock Hits All-Time High, OMER Stock Scales 5-Year Peak – What’s Driving Investors’ Enthusiasm Today? — El precio ya refleja el optimismo; no aporta información nueva sobre fundamentales.
- Stocks making big moves yesterday: AutoZone, Natera, Shopify, Twilio, and Lennar — Listículo sin información sustantiva.
- Why Is Natera (NTRA) Stock Soaring Today — Titular genérico sin datos concretos.
- Here Are Stocks That Hit All-Time Highs Today — Listículo sin información nueva.
Verdict: Hold; momentum and regulatory approvals are positive, but lack of earnings and extreme valuation limit appeal at these prices.
Main risk: The inability to convert its high revenue growth into sustainable profits (operating margin -10.29%) and leverage (DN/EBITDA 3.8) in a rising-rate environment.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →